Browsing by Author "Heng, DYC"
Now showing items 1-1 of 1
-
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, TK; Escudier, B; Powles, T; Tannir, NM; Mainwaring, PN; Rini, BI; Hammers, HJ; Donskov, F; Roth, BJ; Peltola, K (2016-07)